QR-kod

Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.

OBJECTIVE: To examine the proposal that pretreatment low dose desensitisation may reduce the incidence of toxicity of sulphasalazine in the treatment of rheumatoid arthritis (RA). METHODS: A double blind, placebo controlled trial was performed with 422 patients satisfying the American College of Rhe...

Full beskrivning

Sparad:
I publikationen:Ann Rheum Dis
Huvudupphov: McInnes, I B, Porter, D, Murphy, E A, Thomson, E A, Madhok, R, Hunter, J A, Pullar, T, Capell, H A
Materialtyp: Artigo
Språk:Inglês
Utgiven: BMJ Publishing Group 1996
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1010172/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8660109/
https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.55.5.328
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk